English
Syncom Formulations India Ltd Q4 Results
- BSE: 524470
- NSE: SYNCOMF
- ISIN: INE312C01025
- Sector: Biotechnology & Drugs
BSE
12.21
0.00 (0.00%)
0.00 (0.00%)Volume17.63 K
Updated: Fri 23 Jan, 2026 | 09:20:27
NSE
12.48
0.24 (1.96%)
0.24 (1.96%)Volume12.32 K
Updated: Fri 23 Jan, 2026 | 09:07:15
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Syncom Formulations India Ltd Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 132.41 | 114.11 | 16.04% | 66.45 | 99.27% |
| Depreciation/ Amortization | 1.29 | 1.31 | -1.61% | 1.30 | -0.87% |
| Operating Income | 16.47 | 13.43 | 22.69% | 8.13 | 102.66% |
| Net Income | 17.69 | 13.00 | 36.09% | 7.40 | 138.97% |
| Other Operating Expenses Total | 15.78 | 12.20 | 29.38% | 13.76 | 14.72% |
| Net Income Before Taxes | 23.30 | 17.26 | 34.98% | 10.03 | 132.30% |
| Total Revenue | 148.88 | 127.53 | 16.74% | 74.57 | 99.64% |
| Selling/ General/ Admin Expenses Total | 14.97 | 13.95 | 7.36% | 8.69 | 72.28% |
| Diluted Normalized EPS | 0.16 | 0.14 | 14.24% | 0.05 | 247.92% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.